The US economy also witnessed substantial issues in its pharma market. In addition to these, manufacturing & exporting countries around the world saw heightened raw material price inflation followed by supply chain disruption. All these affected the margins of the companies deeply. Synopsis Indian pharmaceutical market flattened after the pandemic led to a massive upsurge … Read more
The companies have received the nod after inking a sub-licensing pact with Medicines Patent Pool (MPP), a UN-based public health organisation working to increase access to life-saving medicines for low- and middle-income countries. Leading drug makers Cadila Pharmaceuticals, Aurobindo Pharma and Torrent Pharmaceuticals on Thursday said they have received a licence to manufacture a generic … Read more
NEW DELHI: Nifty futures on the Singapore Exchange traded 44 points, or 0.26 per cent, higher at 17,304, signaling that Dalal Street was headed for a positive start on Wednesday. Here are a dozen stocks which may buzz the most in today’s trade: Power Grid, Nykaa: FSN E-Commerce Ventures (Nykaa), Power Grid, Tata Power Company, … Read more
The liquidator at Gujarat-based Sterling Biotech, which owes more than Rs 8,100 crore to lenders has called for fresh bids to sell the company as a going concern at a reserve price in the vicinity of Rs 550 crore. Interested parties can submit bids until November 5, the liquidator said last week. The e-auction is … Read more
NEW DELHI: Drug firm Aurobindo Pharma on Wednesday reported a 22.81 per cent rise in its consolidated net profit to Rs 780.68 crore for the quarter ended on June 30, 2020, mainly on account of robust sales in the US market. The company had posted a net profit of Rs 635.68 crore for the corresponding … Read more